0000950170-24-083951.txt : 20240716 0000950170-24-083951.hdr.sgml : 20240716 20240716164036 ACCESSION NUMBER: 0000950170-24-083951 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240715 FILED AS OF DATE: 20240716 DATE AS OF CHANGE: 20240716 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eisner Mark CENTRAL INDEX KEY: 0001834161 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39083 FILM NUMBER: 241120092 MAIL ADDRESS: STREET 1: C/O FIBROGEN, INC. STREET 2: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vir Biotechnology, Inc. CENTRAL INDEX KEY: 0001706431 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 812730369 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1800 OWENS STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-906-4324 MAIL ADDRESS: STREET 1: 1800 OWENS STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 ownership.xml 4 X0508 4 2024-07-15 0001706431 Vir Biotechnology, Inc. VIR 0001834161 Eisner Mark C/O VIR BIOTECHNOLOGY, INC. 1800 OWENS STREET, SUITE 900 SAN FRANCISCO CA 94158 false true false false EVP and Chief Medical Officer false Common Stock 2024-07-15 4 A false 75000 0 A 75000 D Stock Option (Right to Buy) 9.37 2024-07-15 4 A false 150000 0 A 2034-07-14 Common Stock 150000 150000 D Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. 25% of the shares subject to the stock option vest and become exercisable on July 15, 2025, and the remainder vest in 36 equal monthly installments thereafter. /s/ Vanina de Verneuil, Attorney-In-Fact 2024-07-16